Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Dec;87(24):9971-4.
doi: 10.1073/pnas.87.24.9971.

Polyamines potentiate responses of N-methyl-D-aspartate receptors expressed in xenopus oocytes

Affiliations

Polyamines potentiate responses of N-methyl-D-aspartate receptors expressed in xenopus oocytes

J F McGurk et al. Proc Natl Acad Sci U S A. 1990 Dec.

Abstract

Glutamate, the major excitatory neurotransmitter in the central nervous system, activates at least three types of channel-forming receptors defined by the selective agonists N-methyl-D-aspartate (NMDA), kainate, and quisqualate [or more selectively by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)]. Activation of the NMDA receptor requires glycine as well as NMDA or glutamate. Recent studies have provided evidence that certain polyamines potentiate the binding by NMDA receptors of glycine and the open channel blocker MK-801. To determine whether polyamines alter channel opening, we examined their effects on rat brain glutamate receptors expressed in Xenopus oocytes. Our results demonstrate that spermine potentiates the response of the NMDA receptor but has no effect on responses to kainate and quisqualate. Furthermore, spermine increases the maximum response to NMDA and glycine and acts, at least in part, by increasing the apparent affinity of the NMDA receptor/channel complex for glycine. The present findings and the fact that polyamines are a natural constituent of brain suggest that polyamines may play a role in the regulation of glutamatergic transmission.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacol Exp Ther. 1964 Feb;143:199-204 - PubMed
    1. Mol Pharmacol. 1989 Oct;36(4):575-81 - PubMed
    1. J Physiol. 1988 Feb;396:515-33 - PubMed
    1. J Physiol. 1986 Nov;380:175-89 - PubMed
    1. J Neurochem. 1989 Sep;53(3):986-8 - PubMed

Publication types

MeSH terms

LinkOut - more resources